Aimmune Therapeutics completes private placement

Aimmune raised $145 million through the sale of 7.6 million shares at $19.20 in a private placement with the Nestlé Health Science subsidiary of Nestlé S.A. (SIX:NESN, Vevey, Switzerland). The offerin...